A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma)

Clinical trial NCT00442611 · COMPLETED

Trial details

NCT number: NCT00442611
Sponsor: Stanford University
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Scleroderma, Diffuse Scleroderma, Systemic

Start date: 2008-11-01
Primary completion: 2011-06-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.